Benutzer: Gast  Login
Titel:

Keynote-365 cohort C: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC).

Dokumenttyp:
Meeting Abstract
Autor(en):
Fong, Peter C. C.; Retz, Margitta; Drakaki, Alexandra; Massard, Christophe; Berry, William R.; Romano, Emanuela; De Bono, Johann S.; Feyerabend, Susan; Appleman, Leonard Joseph; Conter, Henry Jacob; Sridhar, Srikala S.; Shore, Neal D.; Linch, Mark David; Joshua, Anthony; Gurney, Howard; Wu, Haiyan; Schloss, Charles; Poehlein, Christian Heinrich; Yu, Evan Y.
Zeitschriftentitel:
J Clin Oncol
Jahr:
2019
Band / Volume:
37 Suppl S
Heft / Issue:
7
Volltext / DOI:
doi:10.1200/JCO.2019.37.7_suppl.171
Print-ISSN:
0732-183X
TUM Einrichtung:
Urologische Klinik und Poliklinik
 BibTeX